DELRAY BEACH, Fla., July 8, 2005 (PRIMEZONE) -- Hard To Treat Diseases, Incorporated (HTTD) (Pink Sheets:HTDS) announces today that the Court has rendered a decision on the trial of the Company's claims.
A complete copy of the Court's Memorandum Opinion can be viewed on the Company's Web site at: www.htdsotc.com. Click on Corporate, then click on Legal.
HTTD's CEO, Colm J. King, states, "The Company has spent a lot of time attempting to secure its assets in litigation. HTTD intends to become a respected biotech with the intense focus of negotiating a deal with a major biotech/drug company and attaining the goals of benefiting patients and HTTD's shareholders, the real owners of the company."
On July 7th the Court's Web site announced:
"DECISION RENDERED: Hard to Treat Diseases, Inc. v. Shinn et al., 04-800010. The court has entered a memorandum opinion with findings of fact and conclusions of law holding that (1) the parties' share exchange agreement did close, (2) a Hawaiian corporation known as Shinn Capital owns the right to market a product called Tubercin, and (3) a Florida corporation known as Hard to Treat Diseases, Inc. (Florida) owns 100% of the assets of two Oklahoma corporations: Hard to Treat Diseases, Inc. (Oklahoma) and T-19, Inc. and, therefore, the Florida corporation is entitled to a money judgment against Dr. Ronald Shinn in the sum of $201,620.01. Copies of the court's opinion may be obtained from the clerk of court."
Cautionary Note Regarding Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this news release may contain or constitute forward-looking statements. These forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions of the Private Securities Litigation Act of 1995, Hard to Treat Diseases, Inc. provides the following cautionary statement identifying important factors which, among others, could cause the actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.